Success of rechallenging dabrafenib and trametinib combination therapy after trametinib-induced rhabdomyolysis: a case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Success of rechallenging dabrafenib and trametinib combination therapy after trametinib-induced rhabdomyolysis: a case report

Published:2018-04 Issue:2 Volume:28 Page:151-154
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Muto Yusuke,Ng William,Namikawa Kenjiro,Takahashi Akira,Tsutsumida Arata,Nishida Makiko,Yamazaki Naoya

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference12 articles.

1. Current and future roles of targeted therapy and immunotherapy in advanced melanoma;Olszanski;J Manag Care Spec Pharm,2014

2. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma;Long;J Clin Oncol,2011

3. An overview of the changing landscape of treatment for advanced melanoma;Lee;Pharmacotherapy,2017

4. Resistance to combination BRAF and MEK inhibition in metastatic melanoma: where to next?;Welsh;Eur J Cancer,2016

5. Improved survival with MEK inhibition in BRAF-mutated melanoma;Flaherty;N Engl J Med,2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Langerhans cell histiocytosis: promises and caveats of targeted therapies in high-risk and CNS disease;Hematology;2023-12-08

2. Three cases of malignant melanoma with rhabdomyolysis during combination therapy of dabrafenib and trametinib;Skin Cancer;2022

3. Pharmacology and pharmacovigilance of protein kinase inhibitors;Therapies;2021-11

4. Regulation of OATP1B1 Function by Tyrosine Kinase–mediated Phosphorylation;Clinical Cancer Research;2021-03-04

5. Treatment of Advanced Melanoma: Past, Present and Future;Life;2020-09-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3